Is ADMA Biologics, Inc. (ADMA) a Buy, Sell, or Hold?
ADMA Biologics, Inc.
NASDAQ:ADMA
$8.87 USD
-$0.1 (-1.11%)
- Volume
- 2.7M
- Average Volume
- 5.01M
- Market Capitalization
- $2.06B
- P/E Ratio
- 12.86
- Dividend Yield
- 0.00%
- Price Target
- $21.00
- Year High
- $20.46
- Year Low
- $7.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.95
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.58%
Investors Holding
18
change: -354 | last: 372
Increased Positions
6
change: -194 | last: 200
Reduced Positions
8
change: -108 | last: 116
New Positions
4
change: -65 | last: 69
Sold Positions
343
change: 272 | last: 71
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -34.7694 | last: 0.3477
Total Invested
11.62M
ADMA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $18.24 | 238.3M | $4.35B | $87.63M | $79.88M | $4.34B |
| 2024-12-31 | $17.15 | 233.08M | $4B | $103.15M | $82.12M | $3.98B |
| 2023-12-31 | $4.52 | 223.98M | $1.01B | $51.35M | $141.42M | $1.1B |
| 2022-12-31 | $3.88 | 197.87M | $767.75M | $86.52M | $154.44M | $835.67M |
| 2021-12-31 | $1.41 | 139.58M | $196.81M | $51.09M | $102.92M | $248.64M |
| 2020-12-31 | $1.95 | 86.15M | $167.98M | $55.92M | $97.67M | $209.73M |
| 2019-12-31 | $4.00 | 54.35M | $217.39M | $26.75M | $84.73M | $275.37M |
| 2018-12-31 | $2.39 | 45.19M | $108M | $22.75M | $44.22M | $129.47M |
| 2017-12-31 | $3.21 | 22.9M | $73.5M | $43.11M | $42.97M | $73.36M |
| 2016-12-31 | $5.12 | 12.15M | $62.23M | $9.91M | $20.26M | $72.57M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9.01 | 236.07M | $2.13B | $138.15M | $204.41M | $2.19B |
| 2025-12-31 | $18.24 | 237.97M | $4.34B | $87.63M | $79.88M | $4.33B |
| 2025-09-30 | $14.66 | 238.6M | $3.5B | $61.38M | $83.12M | $3.52B |
| 2025-06-30 | $18.21 | 241.49M | $4.4B | $90.28M | $83.82M | $4.39B |
| 2025-03-31 | $19.84 | 237.78M | $4.72B | $71.62M | $82.01M | $4.73B |
| 2024-12-31 | $17.15 | 236.43M | $4.05B | $103.15M | $82.12M | $4.03B |
| 2024-09-30 | $19.99 | 234.57M | $4.69B | $86.71M | $111.38M | $4.71B |
| 2024-06-30 | $11.55 | 232.42M | $2.68B | $88.24M | $141.4M | $2.74B |
| 2024-03-31 | $6.54 | 228.87M | $1.5B | $45.32M | $141.43M | $1.59B |
| 2023-12-31 | $4.52 | 225.97M | $1.02B | $51.35M | $141.42M | $1.11B |
| 2023-09-30 | $3.58 | 225.28M | $806.49M | $74.16M | $152.97M | $885.31M |
| 2023-06-30 | $3.69 | 222.68M | $821.7M | $62.51M | $151.51M | $910.7M |